Sep 18: 2 Strong Themes — North Korea, Pharma & Biotech
2 strong themes — 1 running · 1 recurred. Top: North Korea +13.0%.
Average change by strong theme
Theme leaders · recent trend
| Theme | Leader | Change | Trend |
|---|---|---|---|
| North Korea | Nuriplan | +19.41% | |
| Pharma & Biotech | Medipost | +7.02% |
On 2018-09-18, North Korea led the session with an average change of 13.02%. All 4 of its stocks closed higher, and the theme came back after a 7-day gap.
Leader Nuriplan rose 19.41% to close at 6134, and news reports said it hit the daily upper limit. Posco M-tech followed with a 17.95% gain on volume of 35039062 shares.
Pharma & Biotech extended its streak to 2 days with an average change of 4.83%. All 5 stocks rose, led by Medipost at 7.02%, while SillaJen added 1.49%.
Today’s Strong Themes at a Glance
| # | Theme | Status | Avg. change | Up/Total | Leader |
|---|---|---|---|---|---|
| 1 | North Korea | recurred after 7 days | +13.0% | 4/4 | Nuriplan |
| 2 | Pharma & Biotech | 2 days running | +4.8% | 5/5 | Medipost |
Theme by Theme
1. North Korea (recurred after 7 days)
- Episode: started 2018-09-18, day 1
| Stock | Change | Close | Leader |
|---|---|---|---|
Nuriplan 069140 | +19.4% | 6,134 | ★ |
Posco M-tech 009520 | +17.9% | 8,870 | |
Tplex 081150 | +9.1% | 3,650 | |
Samryoong 014970 | +5.6% | 6,220 |
Related news
- [fnRASSI]누리플랜, 상한가 기록 — 파이낸셜뉴스 (Korean)
- [이시각 상한가] 누리플랜(▲1820) - 18일 오전 9시41분 — 이투데이 (Korean)
2. Pharma & Biotech (2 days running)
- Episode: started 2018-09-17, day 2
| Stock | Change | Close | Leader |
|---|---|---|---|
Medipost 078160 | +7.0% | 48,666 | ★ |
Kolon TissueGene 950160 | +6.9% | 99,486 | |
Anterogen 065660 | +4.4% | 99,400 | |
Samsung Biologics 207940 | +4.3% | 737,441 | |
SillaJen 215600 | +1.5% | 61,096 |
Related news
- 메디포스트, 7.12% 오르며 체결강도 강세 지속(272%) — 서울경제 (Korean)
- 메디포스트, 전일 대비 7.02% 상승.. 일일회전율은 1.82% 기록 — 서울경제 (Korean)
Closing Thoughts
For North Korea, the open question is whether it can last beyond a 1-day episode. Tplex rose 9.12% and Samryoong 5.6%, so the gains were spread across the group.
For Pharma & Biotech, the next test is whether the 2-day streak continues. Kolon TissueGene rose 6.89% and Samsung Biologics 4.32%, so the gains reached well beyond Medipost.